Heartflow (HTFL) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Key numbers
- Reported EPS
- -$0.07
- Estimate
- -$0.13
- Surprise
- +47.9%
- Revenue (period 2026-06-30)
- $64.1M
- Score at report (before → after)
- 4.5 → 5.6/10
Revenue source: xbrl.
How the report landed
Heartflow (HTFL) reported a narrower loss than forecast — diluted EPS of -$0.07 against the -$0.13 estimate (a 47.9% beat on a still-unprofitable quarter). TrendMatrix's engine moved from Sell (4.5/10) to Buy (Wait) at 5.6/10 after the report.
Coverage in the report window
- HeartFlow Shares Soar Following Strong Q2 Results and Upgraded Guidance — benzinga, 2026-08-14
- Canaccord Genuity Maintains Buy on HeartFlow, Raises Price Target to $45 — benzinga, 2026-08-14
- Morgan Stanley Maintains Equal-Weight on HeartFlow, Raises Price Target to $40 — benzinga, 2026-08-14
Where TrendMatrix's rating stands now
TrendMatrix currently rates HTFL Sell at 5.0/10.
3 of the last 4 quarters beat the estimate; this quarter's +47.9% surprise compares with a +16.8% four-quarter average. Next scheduled report: 2026-11-11.
What supports the rating
- Sector modifier (Healthcare): +0.5
- Strong earnings beat streak (3/4)
What argues against it
- Concentration risk — Product: Heartflow FFRCT Analysis (98.0%)
- Analyst target reached - limited upside remaining
- V7 low-quality RISK_OFF penalty: -0.5 (Q=4.1)
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $48.30
- Price target
- $50.74
- Stop
- $44.92
- Upside to target
- +5.1%
Model outputs from TrendMatrix’s engine as of 2026-09-17 — shown for context, not personalized investment advice.
HTFL at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Health Information Services
- Market cap
- $4.20B
- P/E (fwd)
- -187.8
- 52-week range
- $20.13–$51.78
- Off 52-week high
- 6.7%
- RSI (14)
- 48
- Volume vs avg
- 1.05×
- Score today
- 5.0/10